EcoPhage
Or Yehuda · Founded 2018
About EcoPhage
Ecophage pioneers the development and commercialization of bacteriophages-based bactericides with minimal environmental impact and maximum efficacy, addressing a crucial issue in global agriculture. Annually, an estimated 10% of the world's food production is lost due to plant diseases, with bacterial infections being a significant contributor. Our innovative products harness the power of bacteriophages’viruses uniquely targeting bacteria’to prevent and cure plants, offering nontoxic solutions for bacterial diseases. Our vision is clear – transformation of the global bactericides market in agriculture into more sustainable and safer to human, living and the environment. We are doing that by setting up the mission of revolutionizing agriculture by increasing plant yield, reducing disease-related losses, and promoting sustainability. The foundation of our success lies in a proprietary technological platform co-developed with the prestigious Weizmann Institute of Science. Unlike conventional pesticides that often cause environmental harm and exhibit low efficacy, our bactericides represent a natural solution with minimal negative impact, high specificity, and superior effectiveness. At Ecophage, we are not just combating plant diseases; we are transforming the future of agriculture, one innovative solution at a time.
Company Facts
- Founded: 2018
- Operating status: Operating
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Funding stage: Seed
- Last round: Seed (Apr 2025)
- Website: ecophage.com
- Phone: [email protected]
Social Profiles
Canonical: https://fsome.com/organization/ecophage-8449711 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.